Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value (Tables)

Fair Value (Tables)

3 Months Ended

Mar. 31, 2014

Schedule of financial assets measured at fair value on a recurring basis

Financial assets measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations (in thousands):

	Assets at Fair Value as of March 31, 2014
	Level 1		Level 2		Level 3		Total
Money market funds	$	13,625	$	—	$	—	$	13,625
U. S. treasury bills	—		2,068		—		2,068
Government-sponsored enterprise securities	—		62,827		—		62,827
Corporate bonds and commercial paper	—		116,455		—		116,455

Total	$	13,625	$	181,350	$	—	$	194,975

	Assets at Fair Value as of December 31, 2013
	Level 1		Level 2		Level 3		Total
Money market funds	$	9,059	$	—	$	—	$	9,059
U. S. treasury bills	—		2,085		—		2,085
Government-sponsored enterprise securities	—		67,178		—		67,178

Corporate bonds and commercial paper	—		133,458		—		133,458
Total	$	9,059	$	202,721	$	—	$	211,780